“…Despite approximately 800,000 people taking this drug per year in Japan (information provided by ASKA Pharmaceutical Co., Ltd.), to our knowledge, there are only three reports in the English literature of liver injury suspected due to L-T4 [2,3,4], but all reports ity of the drug lymphocyte stimulation test is 60-70%, based mainly on the analysis of β-lactam hypersensitivity [8]. However, the sensitivity of the drug lymphocyte stimulation test depends on each tested drug [9], and the sensitivity and specificity of the test for L-T4-induced liver injury is not yet known.…”